Trial intelligence / Profile preview

Olmesartan, Irbesartan, and Valsartan in healthy subjects

NCT00185055Phase 4Completed

Sponsor
Daiichi Sankyo Co., Ltd.
Start
Nov 2004
Modality
Small Molecules
01

Overview

A Phase 4 trial of olmesartan in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started Nov 2004; status: completed.

02

Drugs

olmesartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00185055.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00185055.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call